Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
Top Cited Papers
- 3 May 2013
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 340 (6132), 622-626
- https://doi.org/10.1126/science.1234769
Abstract
A number of human cancers harbor somatic point mutations in the genes encoding isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2). These mutations alter residues in the enzyme active sites and confer a gain-of-function in cancer cells, resulting in the accumulation and secretion of the oncometabolite (R)-2-hydroxyglutarate (2HG). We developed a small molecule, AGI-6780, that potently and selectively inhibits the tumor-associated mutant IDH2/R140Q. A crystal structure of AGI-6780 complexed with IDH2/R140Q revealed that the inhibitor binds in an allosteric manner at the dimer interface. The results of steady-state enzymology analysis were consistent with allostery and slow-tight binding by AGI-6780. Treatment with AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro. These data provide proof-of-concept that inhibitors targeting mutant IDH2/R140Q could have potential applications as a differentiation therapy for cancer.Keywords
This publication has 32 references indexed in Scilit:
- Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activationNature, 2012
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- IDH mutation impairs histone demethylation and results in a block to cell differentiationNature, 2012
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Features and development of CootActa Crystallographica Section D-Biological Crystallography, 2010
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsThe Journal of Experimental Medicine, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007
- [20] Processing of X-ray diffraction data collected in oscillation modeMethods in Enzymology, 1997